SG3 Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-16,350
| Closed | -$123K | – | 235 |
|
|
2022
Q2 | $123K | Sell |
16,350
-68,650
| -81% | -$516K | 0.01% | 49 |
|
|
2022
Q1 | $798K | Sell |
85,000
-127,000
| -60% | -$1.19M | 0.02% | 76 |
|
|
2021
Q4 | $1.7M | Buy |
212,000
+52,000
| +33% | +$416K | 0.03% | 64 |
|
|
2021
Q3 | $1.56M | Hold |
160,000
| – | – | 0.05% | 41 |
|
|
2021
Q2 | $1.58M | Sell |
160,000
-30,000
| -16% | -$297K | 0.06% | 32 |
|
|
2021
Q1 | $2.19M | Buy |
190,000
+39,700
| +26% | +$458K | 0.05% | 29 |
|
|
2020
Q4 | $1.45M | Buy |
150,300
+70,300
| +88% | +$678K | 0.03% | 46 |
|
|
2020
Q3 | $721K | Sell |
80,000
-20,000
| -20% | -$180K | 0.03% | 75 |
|
|
2020
Q2 | $1.23M | Buy |
+100,000
| New | +$1.23M | 0.09% | 32 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 247 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 202 |
|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$157K | – | 294 |
|
|
2019
Q1 | $157K | Hold |
10,000
| – | – | 0.02% | 45 |
|
|
2018
Q4 | $154K | Buy |
+10,000
| New | +$154K | 0.04% | 26 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 185 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 186 |
|